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ABSTRACT To study the possibility of glycine-directed
amidation in rat brain, we synthesized the substrate p-Glu-
His-Pro-Gly-OH. Adult and neonatal rat brain and adult rat
pituitary were sonicated, frozen and thawed, and fractionated
by gel permeation chromatography, and fractions from each
tissue were assayed for enzymatic activity capable of convert-
ing this model substrate into thyrotropin-releasing hormone.
We report the presence in rat brain and rat pituitary of two
enzymes catalyzing conversion of p-Glu-His-Pro-Gly-OH into
thyrotropin-releasing hormone. Based on the differing chemi-
cal and physical properties of these two enzymes and their dif-
fering affinities for a number of p-Glu-His-Pro-aa-OH analogs
(in which aa = glycine, f-alanine, -butyric acid, and &-ami-
novaleric acid), we conclude that there are two distinct enzy-
matic processes for the terminal amidation of peptides in brain
and that COOH-terminal extensions other than glycine are ca-
pable of directing COOH-terminal amidation.
The majority of physiological secretory polypeptides are
COOH-terminal amides. Because all protein synthesis with-
in mammalian cells is ribosomal (glutathione being the single
known exception), secretory polypeptides are generally be-
lieved to be derived from the enzymatic, post-translational
processing in the endoplasmic reticulum of considerably
larger precursors (1-5). Based on these considerations and
other circumstantial evidence (6-10), several authors have
postulated that a COOH-terminal glycine may be a recogni-
tion "sequence" leading to enzymatic amidation of the
daughter polypeptide prior to release. Recently, Bradbury et
al. (11) have discovered, and others (12) have confirmed, the
presence of a glycine-directed amidase in neurosecretory
granules prepared from porcine pituitary.
Despite the fact that many neurotransmitter polypeptides
in the central nervous system are COOH-terminal amides,
glycine-directed COOH-terminal amidation has never been
demonstrated in brain. The purpose of this study, therefore,
was to determine whether the model peptide p-Glu-His-Pro-
Gly-OH could be converted into p-Glu-His-Pro-NH2 (thyro-
tropin-releasing hormone; TRH) by proteins present in rat
brain. This substrate was chosen because it provided the
dual opportunity to search for glycine-directed amidases in
brain and to study the possible biosynthetic pathway for
TRH, which is currently unknown. Our successful studies
form the basis of this report.
METHODS
Chemicals. -y-Aminobutyryl-His-Pro-NH2 (GABA-His-
Pro-NH2) was synthesized as described (13, 14).
p-Glu-His-Pro-NH2 (TRH) was purchased from Peninsula
Laboratories (San Carlos, CA), and its structure was veri-
fied by mass spectrometry (15).
Pyroglutamylhistidylprolyl amino acid analogs (p-Glu-His-
Pro-aa-OH): Pyroglutamylhistidine methyl ester (p-Glu-His-
OCH3) was prepared essentially by the methods of Folkers
and co-workers (16) and Geiger et al. (17) and purified by
silica gel chromatography using 20% anhydrous methanol
and chloroform as the eluate. p-Glu-His-OCH3 was saponi-
fied in ice-cold 0.1 M NaOH for 5-8 min, the pH was adjust-
ed to 3.9 (theoretical isoelectric point), and the sample was
freeze-dried and used without further purification.
Pro-Gly-OCH3 HCI, Pro-3-Ala-OCH HCI, Pro-GABA-
OCH3 HCl, or Pro-3-AVa-OCH3 HCl (6-AVa, &-aminova-
leric acid) were prepared and coupled to p-Glu-His-OH using
methods detailed elsewhere (13). After saponification of the
methyl esters, p-Glu-His-Pro-Gly-OH, p-Glu-His-Pro-,B3Ala-
OH, p-Glu-His-Pro-GABA-OH, and p-Glu-His-Pro-B-AVa-
OH were purified by silica gel column chromatography using
acetone/38% acetic acid (60:40).
Analytical. Mass spectrometry. Mass fragmentation spec-
tra of solid probe samples were obtained using electron im-
pact ionization in a Finnegan 3300 GC-MS.
Amino acid analysis. Peptides were hydrolyzed in 4 M
methane sulfonic acid by the method of Blackburn (18) fol-
lowed by amino acid ahalysis on an Aminex HPC (Bio-Rad)
column by the post-column derivatization method of Voelter
and Zech (19). Alternatively, samples for amino acid analy-
sis by gas chromatography were hydrolyzed in constant boil-
ing HCl and analyzed according to the method of Gehrke and
Stalling (20).
Thin layer chromatography. TLC was carried out on silica
gel plates using the following three solvent systems: (i) sol-
vent system A, methanol/methylene chloride (40:60); (ii)
solvent system B, methanol/chloroform/38% acetic acid
(40:60:20); (iii) solvent system C, methanol/chloroform/con-
centrated ammonium hydroxide (60:40:20). Where appropri-
ate, TLC plates were developed by iodine vapor or by spray-
ing with an aqueous solution of ninhydrin or the Pauly rea-
gent. Sample loads were 10-20 ,g for each peptide.
TRH radioimmunoassay. Antibodies were raised to a bo-
vine serum albumin-GABA-His-Pro-NH2 conjugate by im-
munization of New Zealand White rabbits by the method of
Vitakaitis et al. (21). Antibodies developed against this im-
munogen have a high affinity for TRH (Kas, 2.4 x 10-9 M),
do not crossreact with any other substances present in rat
brain (Ka for p-Glu-His-Pro-COOH is 4.8 x 10- M, and Ka
for His-Pro-diketopiperazine is 4 x 10-4 M), and have a
crossreactivity for p-Glu-His-Pro-Gly-OH of <0.0005% (14).
The lack of affinity of this antiserum for the p-Glu-His-Pro-
Gly-OH, when compared to the affinity for this tetrapeptide
of antiserum generated by standard techniques, allows the
Abbreviations: TRH, thyrotropin-releasing hormone; GABA, y.
aminobutyric acid.
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accurate measurement of TRH despite the presence of sig-
nificant quantities of p-Glu-His-Pro-Gly-OH. This RIA is
presented in detail elsewhere (14, 22).
Sample preparation. Neonatal rats (Sprague-Dawley 8-
10 days old) were decapitated, their brains were removed,
and the cerebellum was separated. The tissues were then
sonicated in ice-cold 0.05 M Tris HCl buffer (pH 7.0) fol-
lowed by one cycle of freeze-thawing. The sonicate was cen-
trifuged at 30,000 x g for 30 min at 40C, and the clear super-
natant was applied to a 100 x 3.5 cm column of Sephadex
G-100 previously equilibrated with 200 mM sodium chlo-
ride/0.05 M Tris buffer, pH 6.5. Fractions of 3.5 ml were
collected and assayed for the presence of enzymatic activity
cap Die of converting p-Glu-His-Pro-Gly-OH or other ana-
logs into TRH as described below. The brains and pituitaries
from adult rats were collected, processed, and chromato-
graphed in a similar manner. Where indicated, subcellular
fractionation was carried out on sucrose gradients by the
method of DeRobertis et al. (23).
Analysis for the Enzymatic Conversion of p-Glu-His-Pro-aa-
OH into TRH. Aliquots (250 tkl) from the fractionation of
neonatal or adult rat brain or adult rat pituitaries were incu-
bated at 370C for 5 hr in the presence of 5 Mg of p-Glu-His-
Pro-Gly-OH (final concentration, 0.05 mM). Where indicat-
ed, N-ethylmaleimide was added to a final concentration of
0.5 mM. After identification of peaks of enzymatic activity,
substrate affinities were determined by adding various con-
centrations of each of the model substrates. Control incuba-
tions contained all ingredients but were frozen immediately
instead of incubated. After incubation, the samples were fro-
zen, lyophilized, and extracted with 2.5 ml of absolute meth-
anol. The methanolic extracts were centrifuged, the superna-
tants were transferred to clean test tubes, and the contents
were dried under a stream of nitrogen. The samples were
then dissolved in 1 ml of 0.05 M pyridine and applied to 7 x
0.5 cm columns of Dowex 1 (anion exchange resin), which
had been extensively washed and previously equilibrated
with 0.05 M pyridine. The columns were washed with a fur-
ther 2.5 ml of 0.05 M pyridine and the eluate was lyophilized.
The dried samples were then dissolved in 2 ml of absolute
methanol, and the samples were removed for either product
verification by TLC or directly for RIA. The overall recov-
ery for internal standards carried through the extraction pro-
cedure is between 90% and 95%. The extraction procedure
over Dowex also removes >98% of the p-Glu-His-Pro-aa-
OH from the final RIA sample.
In other experiments, samples of the fractionation of rat
brain and pituitaries were subjected to boiling before incuba-
tion.
Verification of Product. To verify the identity of the enzy-
matic product, samples of the final methanolic extracts were
applied to silica gel plates and eluted either with solvent sys-
tem B or C. After development, the TLC plates were dried,
divided into 12 fractions, and each fraction was extracted
with absolute methanol. After methanolic extraction, the
samples were centrifuged and the supernatant was removed,
dried, and assayed for TRH by the RIA described above.
Internal standards were carried through the exact same pro-
cedures.
RESULTS
After purification, all of the p-Glu-His-Pro-aa-OH analogs
chromatographed as single, Pauly-positive, ninhydrin-nega-
tive spots on silica gel thin-layer plates using solvent system
B. The amino acid composition (molar ratios of amino acid
residues) and Rf for each peptide analog are as follows:
(i) p-Glu-His-Pro-Gly-OH: Rf, 0.4; Glu (expected, 1.00;








FIG. 1. Formation of TRH from p-Glu-His-Pro-Gly-OH by frac-
tions of adult rat pituitary chromatographed on Sephadex G-100.
Solid line in this and other figures represents absorption at 254 nm.
(ii) p-His-Glu-Pro-jp-Ala-OH: Rf, 0.56; Glu -(1.00; 0.93),
His (1.00; 1.00), Pro (1.00; 0.95), f3Ala (1.00; 0.98);
(iii) p-Glu-His-Pro-GABA-OH: Rf, 0.73; Glu (1.00; 1.07),
His (1.00; 1.00), GABA (1.00; 1.01);
(iv) p-Glu-His-Pro-8-Val-OH: Rf, 0.69; Glu (1.00; 0.91),
His (1.00; 1.00), Pro (1.00; 1.10), 8-Val (1.00; 1.03).
Incubation of p-Glu-His-Pro-Gly-OH with fractions of rat
pituitary obtained after gel chromatography demonstrated
two peaks of enzymatic activity capable of converting this
tetrapeptide into p-Glu-His-Pro-NH2 (TRH). The first of
these proteins had an apparent molecular size between 60
and 70 kDa (as determined by calibration with standard pro-
teins of known molecular size), whereas the second peak
eluted after the salt peak, implying that it was either consid-
erably smaller or was retarded by the polysaccharide matrix
of the Sephadex (Fig. 1). Incubation of fractions of rat brains
with p-Glu-His-Pro-Gly-OH also gave two peaks of enzy-
matic activity, although this profile of activity varied slightly
from that of rat pituitary. Whereas the second peak of enzy-
matic activity from rat brain appeared similar to that ob-
tained from adult rat pituitary, the first peak of activity was
considerably less and appeared to elute some fractions later
than that observed for the pituitary enzymes (Fig. 2). Incu-
bation of known amounts of TRH with each of the fractions
obtained from rat brain gave a profile of TRH degradative
activity as shown in Fig. 3. This degradative activity signifi-
cantly overlaps the first peak of amidating activity and im-
plies that the dissimilarity between the profiles of enzymatic
activity obtained from rat pituitary and from rat brain is due
to enzymatic destruction of TRH product and/or substrate.
Based on our previous demonstration that the enzymes ca-
tabolizing TRH are dependent on functional sulfhydryl
groups (24), fractions of rat brains were again assayed for










FIG. 2. Formation of TRH from p-Glu-His-Pro-Gly-OH by frac-
tions of neonatal rat brain chromatographed on Sephadex G-100 and
assayed in the absence of N-ethylmaleimide.
Neurobiology: Kizer et aL











FIG. 3. Degradation ofTRH by fractions of neonatal rat brain in
the absence of N-ethylmaleimide. See legend to Fig. 2 for details.
with 0.5 mM N-ethylmaleimide added to the first 60 fractions
(Fig. 4). Under these conditions, the majority of the degrada-
tive enzymes were inhibited, and the first peak of amidating
activity in rat brain was greatly enhanced: its chromato-
graphic profile now similar to that obtained for rat pituitary.
Some degradative activity still persisted, however, in the
very early chromatographic fractions, which could not be
completely inhibited by the addition of N-ethylmaleimide.
There was no inhibition of the first peak of glycine-directed
amidase activity by 0.5 mM N-ethylmaleimide.
The authenticity of the product resulting from the incuba-
tion of p-Glu-His-Pro-Gly-OH with each of the protein peaks
was verified by comparing its chromatographic properties to
TRH standards on TLC using two different solvent systems
(B and C). In both systems, the product from the two enzy-
matic reactions comigrated with standards of TRH (Figs. 5
and 6; data from solvent system C not shown). The conver-
sion of p-Glu-His-Pro-Gly-OH into TRH by both the first
and second peaks of enzymatic activity was readily inhibited
by 5 min of boiling. Furthermore, in no case was TRH found
in the fractions of either brains or pituitaries before incuba-
tion. This absence ofTRH results from the active catabolism
of TRH by degradative enzymes that are highly active even
during preparation of tissue at 40C (24).
In further studies, we compared the chemical and physical
properties and the substrate specificities of the two enzyme
peaks (Table 1). Although both enzymes are metalloproteins
and have similar pH optima, the peak 1 enzyme appeared to
have an absolute specificity for a COOH-terminal glycine,
and its catalytic activity was not dependent on intact hy-
droxyl or sulfhydryl groups. The second peak of enzymatic
activity, however, had a wider substrate specificity with p-
Glu-His-Pro-,l-Ala-OH having the highest affinity for the en-
zyme. The catalytic activity of this second enzyme is depen-
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FIG. 5. (A) TLC (system B) of product from incubation of frac-
tions 37-41 from neonatal rat brain with p-Glu-His-Pro-Gly-OH. (B)
Same as A, but with added internal standard of authentic TRH.
more, the retardation of the peak 2 enzymatic activity by the
polysaccharide matrix of Sephadex suggests that this en-
zyme is either considerably smaller than or more basic than
peak 1.
DISCUSSION
In these studies, we have observed glycine-directed, COOH-
















FIG. 4. Formation ofTRH from p-Glu-His-Pro-Gly-OH by frac-
tions of neonatal rat brain assayed in the presence of 0.5 mM N-





FIG. 6. (A) TLC (system B) of product from incubation of frac-
tions 77-87 from neonatal rat brain with p-Glu-His-Pro-Gly-OH. (B)
Same as A, but with added internal standard of authentic TRH.
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Table 1. Substrate affinities and chemical and physical
properties of brain glycine amidases
Peak 1 Peak 2
Substrate, Km
p-Glu-His-Pro-Gly-OH 30 jM 100 AiM
p-Glu-His-Pro-l3-Ala-OH 50 ,uM
p-Glu-His-Pro-GABA-OH 560 ILM
p-Glu-His-Pro-&-AVa - 1260 ;iM
pH optimum 5.9-6.0 6.2-6.3
PhMeSO2F
2 mM No effect Inhibits
10 mM No effect Inhibits
N-Ethylmaleimide
2 mM No effect Inhibits
10 mM Slight inhibition Inhibits
EDTA
2 mM Inhibits Stimulates
10 mM Inhibits ± Inhibits
1,10-Phenanthroline
2 mM Inhibits Inhibits
10 mM Inhibits Inhibits
Subcellular localization 70% soluble
Neonatal 30% particulate 100%o particulate
Adult 100% particulate 100% particulate
PhMeSO2F, phenylmethylsulfonyl fluoride.
Rat brain and adult rat pituitary both contain two protein
peaks capable of enzymatically converting p-Glu-His-Pro-
Gly-OH into TRH. Although these observations may repre-
sent the initial demonstration of glycine-directed peptide
amidation in brain, the original observation of glycine amida-
tion is credited to Bradbury et al. (11). In an elegant study,
these authors demonstrated the conversion of the model tri-
peptide, D-Tyr-Val-Gly-OH, to D-Tyr-Val-NH2 by prepara-
tion of secretory granules from bovine pituitary. Although
our studies can be viewed as confirming the findings of these
authors, our results differ in two significant aspects: First, in
both pituitary and brain we find two enzymes catalyzing
COOH-terminal amidation, whereas these authors found
only one in bovine pituitary. Second, our results demon-
strate that COOH-terminal peptide extensions other than
glycine may be capable of directing COOH-terminal amida-
tion.
One reason for the apparent failure of the studies by Brad-
bury et al. (11) to detect a second peak of amidating activity
may be that they partially purified their enzyme from a prep-
aration of secretory granules, whereas our initial fractions
were obtained from whole-cell sonicates. In recent studies,
we have observed that during the pelleting of the membrane
fraction in isotonic sucrose, the enzymatic activity of peak 2
is lost.
The importance of these observations lies in their further-
ing our understanding of the processing of precursor hor-
mones into physiologically active daughter peptides. At
present, general theory supposes that all hormones are syn-
thesized ribosomally as part of a larger prohormone se-
quence (25). Synthesis of the prohormone is probably initiat-
ed by the synthesis of a 17-31 amino acid long "signal-se-
quence," which serves as a recognition site for the binding of
the nascent prohormone and ribosomes to the endoplasmic
reticulum (25). It is also theorized that on binding to the en-
doplasmic reticulum, the nascent hormone is inserted into
the endoplasmic reticulum and the signal-sequence is split
from the NH2 terminus of the prohormone by a signal pepti-
dase (25). Furthermore, processing is believed to take place
by the action of "trypsin-like" activity, which fragments the
prohormone at sites containing basic amino acid residues (1-
5, 25). Subsequently, the basic amino acids are removed,
and hormones containing a free COOH-terminus are then
ready for release. Until recently, however, the mechanism of
COOH-terminal amidation was not understood even though
structural analysis of several prohormones suggested the
presence of a COOH-terminal glycine extension of the future
daughter hormone. Thus, the observations of Bradbury et al.
(11) and the observations of this report suggest the presence
of enzymes in pituitary and brain that are capable of carrying
out this important COOH-terminal modification of secretory
peptides and hormones. We further predict that future struc-
tural analyses of prohormones will discover COOH-terminal
extensions of the daughter peptide other than glycine.
The enzyme of Bradbury et al. (our enzyme 1) amidates a
variety of peptide-glycine substrates (11, 26). Although the
mechanism of catalysis by this first enzyme has not been
completely elucidated, the work of these authors suggests
that the ultimate source for the nitrogen in the terminal car-
boxamide is glycine itself, the result of the enzymatic pro-
cess being a COOH-terminally amidated peptide and
glyoxylic acid. Based on our observations of differing sub-
strate specificities and chemical properties for the two brain
amidases, we suggest that the catalytic mechanisms of the
two enzymes may be dissimilar.
It is important to note that, although we have demonstrat-
ed the conversion of a model tetrapeptide ending in glycine
into TRH by enzymes present in rat brain and pituitary,
these observations do not in themselves prove that this is the
mechanism for the biosynthesis ofTRH in vivo. Such a con-
clusion can only be derived from the demonstration that an
endogenous protein, when incubated in the presence of one
or the other of these enzymes, gives rise to TRH. Neverthe-
less, investigations of this possibility will enhance our under-
standing of the mechanism of the biosynthesis not only of
TRH but also of a wide variety of other COOH-terminally
amidated proteins.
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